跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VORICONAZOLE PFS GPPL voriconazole 40 mg/mL powder for oral suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
VORICONAZOLE PFS GPPL voriconazole 40 mg/mL powder for oral suspension bottle
Approved
STANDARD
VORICONAZOLE PFS GPPL voriconazole 40 mg/mL powder for oral suspension bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5fce27c771d13388
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
5fce27c771d13388
Product Name
VORICONAZOLE PFS GPPL voriconazole 40 mg/mL powder for oral suspension bottle
Artg Id
293386
Artg Name
VORICONAZOLE PFS GPPL voriconazole 40 mg/mL powder for oral suspension bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2019-03-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5fce27c771d13388
Type
Standard
Back to TGA Approvals